| Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis P Papatheodorou, C Zamboglou, S Genisyuerek, G Guttenberg, ... PloS one 5 (5), e10673, 2010 | 196 | 2010 |
| Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison … C Zamboglou, V Drendel, CA Jilg, HC Rischke, TI Beck, ... Theranostics 7 (1), 228, 2017 | 158 | 2017 |
| Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate-and high-risk prostate cancer-a … C Zamboglou, M Carles, T Fechter, S Kiefer, K Reichel, TF Fassbender, ... Theranostics 9 (9), 2595, 2019 | 116 | 2019 |
| 68Ga-HBED-CC-PSMA PET/CT versus histopathology in primary localized prostate cancer: a voxel-wise comparison C Zamboglou, F Schiller, T Fechter, G Wieser, CA Jilg, A Chirindel, ... Theranostics 6 (10), 1619, 2016 | 112 | 2016 |
| [68Ga-] PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard … AS Bettermann, C Zamboglou, S Kiefer, CA Jilg, S Spohn, ... Radiotherapy and Oncology 141, 214-219, 2019 | 93 | 2019 |
| MRI versus 68Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer C Zamboglou, G Wieser, S Hennies, I Rempel, S Kirste, M Soschynski, ... European journal of nuclear medicine and molecular imaging 43, 889-897, 2016 | 89 | 2016 |
| Outcome after PSMA PET/CT–based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a 2-institution retrospective analysis NS Schmidt-Hegemann, C Stief, TH Kim, C Eze, S Kirste, I Strouthos, M Li, ... Journal of Nuclear Medicine 60 (2), 227-233, 2019 | 74 | 2019 |
| Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference C Zamboglou, B Thomann, K Koubar, P Bronsert, T Krauss, HC Rischke, ... Radiation oncology 13, 1-9, 2018 | 61 | 2018 |
| Impact of 68Ga-PSMA PET/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis NS Schmidt-Hegemann, C Eze, M Li, P Rogowski, C Schaefer, C Stief, ... Journal of Nuclear Medicine 60 (7), 963-970, 2019 | 59 | 2019 |
| Radiomics in prostate cancer imaging for a personalized treatment approach-current aspects of methodology and a systematic review on validated studies SKB Spohn, AS Bettermann, F Bamberg, M Benndorf, M Mix, NH Nicolay, ... Theranostics 11 (16), 8027, 2021 | 50 | 2021 |
| Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference C Zamboglou, TF Fassbender, L Steffan, F Schiller, T Fechter, M Carles, ... Radiotherapy and Oncology 141, 208-213, 2019 | 48 | 2019 |
| Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 … C Zamboglou, AS Bettermann, C Gratzke, M Mix, J Ruf, S Kiefer, CA Jilg, ... European journal of nuclear medicine and molecular imaging 48, 1987-1997, 2021 | 45 | 2021 |
| Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET/CT: a planning study based on histopathology reference C Zamboglou, I Sachpazidis, K Koubar, V Drendel, R Wiehle, S Kirste, ... Radiotherapy and Oncology 123 (3), 472-477, 2017 | 45 | 2017 |
| PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives S Zschaeck, F Lohaus, M Beck, G Habl, S Kroeze, C Zamboglou, ... Radiation oncology 13, 1-9, 2018 | 43 | 2018 |
| Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network D Kostyszyn, T Fechter, N Bartl, AL Grosu, C Gratzke, A Sigle, M Mix, ... Journal of Nuclear Medicine 62 (6), 823-828, 2021 | 39 | 2021 |
| Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective … S Spohn, C Jaegle, TF Fassbender, T Sprave, E Gkika, NH Nicolay, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 2796-2803, 2020 | 38 | 2020 |
| Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology DD Gunashekar, L Bielak, L Hägele, B Oerther, M Benndorf, AL Grosu, ... Radiation Oncology 17 (1), 65, 2022 | 29 | 2022 |
| Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary … SKB Spohn, M Kramer, S Kiefer, P Bronsert, A Sigle, ... Frontiers in oncology 10, 600690, 2020 | 29 | 2020 |
| Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer TF Fassbender, F Schiller, C Zamboglou, V Drendel, S Kiefer, CA Jilg, ... EJNMMI research 10, 1-11, 2020 | 29 | 2020 |
| The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary … C Zamboglou, CM Klein, B Thomann, TF Fassbender, HC Rischke, ... Radiation oncology 13, 1-8, 2018 | 29 | 2018 |
